The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials

BACKGROUND: Vortioxetine is an investigational multimodal antidepressant. We conducted this meta-analysis to assess the efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder (MDD). METHODS: Randomized controlled trials (RCTs) published in PubMed, Web of Science, Emb...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guangjian, Wang, Xu, Ma, Dihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778778/
https://www.ncbi.nlm.nih.gov/pubmed/27013879
http://dx.doi.org/10.2147/NDT.S103173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778778/
https://www.ncbi.nlm.nih.gov/pubmed/27013879
http://dx.doi.org/10.2147/NDT.S103173

Ejemplares similares